𝕏
Latest

Author

Imogen Reyes

Senior writer, legal and rare disease markets

Imogen Reyes covers pharmaceutical litigation, settlements and patent disputes for PharmaWire, and writes its long-form rare disease market guides.

Latest from Imogen Reyes

Deals

Evommune Inks Up to $1.1bn Deal for Hinova Autoimmune Drug

Evommune (EVMN) has licensed rights to an experimental autoimmune disease treatment from China’s Hinova Pharmaceuticals (688302.SS) in a deal worth up to about $1.1bn in milestone payments. Under the agreement, the California-based drug…

Legal

Florida sues PBMs over alleged pharmacy price-fixing scheme

Florida's attorney general has filed suit against pharmacy benefit managers Express Scripts, a unit of Cigna (CI), and Prime Therapeutics, accusing the rival drug middlemen of engaging in illegal price-fixing that has gutted reimbursements…